Literature DB >> 17171860

Atrial natriuretic peptide plasma levels during cardiac surgery.

P Flezzani1, R W McIntyre, Y T Xuan, Y F Su, J B Leslie, W D Watkins.   

Abstract

In this investigation, the hypothesis was tested that patients with valvular heart disease have higher atrial natriuretic peptide (ANP) plasma levels than patients with coronary artery disease during cardiac surgery. Six patients scheduled for valve replacement (group V) and seven scheduled for coronary artery bypass grafting (CABG) (group C) were studied. ANP plasma levels and hemodynamic measurements were obtained at several times during surgery. ANP levels were elevated in both groups compared to those measured in healthy volunteers; and ANP levels in valvular patients were found to be higher than in the CABG patients. In addition, isotonic fluid loading, rewarming during cardiopulmonary bypass, and weaning from cardiopulmonary bypass increased ANP from baseline in group C. Mean arterial pressure and ANP levels correlated in group C. Ejection fraction, pulmonary artery diastolic pressure, and right atrial pressure did not correlate with ANP levels in either group. In conclusion, patients with valvular heart disease have higher ANP levels during surgery compared to patients with coronary artery disease. This difference probably relates to different pressure and volume loads on atrial tissue.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 17171860     DOI: 10.1016/0888-6296(88)90305-5

Source DB:  PubMed          Journal:  J Cardiothorac Anesth        ISSN: 0888-6296


  3 in total

1.  Atrial natriuretic factor and cardiopulmonary bypass.

Authors:  M Hynynen
Journal:  Can J Anaesth       Date:  1990-05       Impact factor: 5.063

2.  Perioperative changes in plasma brain natriuretic peptide concentrations in patients undergoing cardiac surgery.

Authors:  K Morimoto; T Mori; S Ishiguro; N Matsuda; Y Hara; H Kuroda
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

3.  Atrial natriuretic peptide responses during anaesthesia in patients with refractory cardiomyopathies.

Authors:  S N Glisson; G E Gutzke; R Pifarre; T L Rao
Journal:  Can J Anaesth       Date:  1991-07       Impact factor: 5.063

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.